Literature DB >> 17934733

[Primary cerebellar T-cell lymphoma].

A Zimpfer1, M Wasner, F Fend, M Tolnay, S Dirnhofer.   

Abstract

Primary central nervous system T-cell lymphomas are rare and have to be differentiated from reactive lesions. It is therefore essential to use all possible tools to establish the diagnosis, including immunohistochemistry, molecular genetic analysis, and/or cytogenetic methods. In this paper we present the case of a primary cerebellar T-cell lymphoma in a 50-year-old man; a clonal T-cell receptor gene rearrangement was documented. After two cycles of methotrexate therapy the patient developed Pneumocystis carinii-induced pneumonia, dying 10 weeks after his diagnosis. The autopsy did not reveal any residual tumour.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17934733     DOI: 10.1007/s00292-007-0951-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  9 in total

Review 1.  Primary CNS lymphoma.

Authors:  Fred H Hochberg; Joachim M Baehring; Ephraim P Hochberg
Journal:  Nat Clin Pract Neurol       Date:  2007-01

2.  Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group.

Authors:  Tamara N Shenkier; Jean-Yves Blay; Brian Patrick O'Neill; Philip Poortmans; Eckhard Thiel; Kristoph Jahnke; Lauren E Abrey; Edward Neuwelt; Richard Tsang; Tracy Batchelor; Nancy Harris; Andrés J M Ferreri; Maurilio Ponzoni; Peter O'Brien; James Rubenstein; Joseph M Connors
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

3.  Non-HTLV-I associated pleomorphic T-cell lymphoma of the brain mimicking post-vaccinal acute inflammatory demyelination.

Authors:  J Wanschitz; J A Hainfellner; I Simonitsch; M Schnizer; E Deisenhammer; H Terunuma; Y Iwasaki; H Budka
Journal:  Neuropathol Appl Neurobiol       Date:  1997-02       Impact factor: 8.090

4.  Intracranial inflammatory tumors: a survey of their various etiologies by presentation of 5 cases.

Authors:  E Postler; A Bornemann; M Skalej; S Kröber; E Kaiserling; J Wickboldt; R Meyermann
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

5.  Primary peripheral T-cell lymphoma of the central nervous system.

Authors:  A M Stark; M Tiemann; L Dörner; E Melnikowa; H M Mehdorn; U Blömer
Journal:  Zentralbl Neurochir       Date:  2004-11

6.  Primary central nervous system lymphoma in Japan: a nationwide survey.

Authors:  N Hayabuchi; Y Shibamoto; Y Onizuka
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-05-01       Impact factor: 7.038

Review 7.  Primary central nervous system lymphomas--new pathological developments.

Authors:  K A Jellinger; W Paulus
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 8.  Primary central nervous system lymphoma.

Authors:  J W Grant; P G Isaacson
Journal:  Brain Pathol       Date:  1992-04       Impact factor: 6.508

9.  Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002.

Authors:  Andrés J M Ferreri; Lauren E Abrey; Jean-Yves Blay; Bettina Borisch; Jacob Hochman; Edward A Neuwelt; Joachim Yahalom; Emanuele Zucca; Franco Cavalli; James Armitage; Tracy Batchelor
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.